FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-5900fje.
This Article
Right arrow Summary
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.06-5900fjev1
20/12/2142    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.-g.
Right arrow Articles by Wu, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.-g.
Right arrow Articles by Wu, L.
(The FASEB Journal. 2006;20:2142-2144.)
© 2006 FASEB

Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RAR{alpha}

Jian-guang Wang*, Lora W. Barsky{dagger}, Elai Davicioni§, Kenneth I. Weinberg{dagger},§, Timothy J. Triche*,§, Xiao-kun Zhang{ddagger} and Lingtao Wu*,§,1

* Department of Pathology,

{dagger} Division of Research Immunology/BMT, Childrens Hospital Los Angeles Saban Research Institute, Los Angeles, California, USA;

{ddagger} The Burnham Institute Cancer Center, La Jolla, California, USA;

§ University of Southern California Keck School of Medicine, Los Angeles, California, USA

1Correspondence: Department of Pathology, MS# 103, Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, 4650 Sunset Blvd., Los Angeles, CA 90027 USA. E-mail: lingtaow{at}usc.edu

ABSTRACT

Acute promyelocytic leukemia (APL) cells express promyelocytic leukemia/retinoic acid receptor alpha (PML/RAR{alpha}) fusion protein, which leads to the blocking of APL cell differentiation. Treatment of APL with all-trans-retinoic acid (ATRA) induces disease remission by in vivo differentiation of APL cells. Differentiation requires cell cycle exit; yet how ATRA couples cell cycle exit to differentiation of APL remains largely unknown. We previously found that ATRA-induced cell differentiation accompanies ubiquitination-proteolysis of ménage à trois 1 (MAT1), an assembly factor and targeting subunit of cyclin-dependent kinase (CDK)-activating kinase (CAK) that regulates G1 exit. We report here that CAK binds to and phosphorylates PML/RAR{alpha} in actively proliferating APL cells. In response to ATRA, PML/RAR{alpha} is dissociated from CAK, leading to MAT1 degradation, G1 arrest, and decreased CAK phosphorylation of PML/RAR{alpha}. CAK phosphorylation of PML/RAR{alpha} is inhibited when MAT1 levels are reduced. Both MAT1 degradation and PML/RAR{alpha} hypophosphorylation occur in ATRA-induced G1-arresting cells undergoing differentiation but not in the synchronized G1 cells that do not differentiate. These findings reveal a novel ATRA signaling on APL cell differentiation, in which ATRA coordinates G1 arrest and transition into differentiation by inducing MAT1 degradation and PML/RAR{alpha} hypophosphorylation through disrupting PML/RAR{alpha} binding and phosphorylation by CAK.—Wang, J.-g., Barsky, L. W., Davicioni, E., Weinberg, K. I., Triche, T. J., Zhang, X.-k., and Wu, L. Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RAR{alpha}.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
C. Valli, G. Paroni, A. M. Di Francesco, R. Riccardi, M. Tavecchio, E. Erba, A. Boldetti, M. Gianni', M. Fratelli, C. Pisano, et al.
Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity
Mol. Cancer Ther., September 1, 2008; 7(9): 2941 - 2954.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
P. Luo, A. Wang, K. J. Payne, H. Peng, J.-g. Wang, Y. K. Parrish, J. W. Rogerio, T. J. Triche, Q. He, and L. Wu
Intrinsic Retinoic Acid Receptor {alpha}-Cyclin-Dependent Kinase-Activating Kinase Signaling Involves Coordination of the Restricted Proliferation and Granulocytic Differentiation of Human Hematopoietic Stem Cells
Stem Cells, October 1, 2007; 25(10): 2628 - 2637.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.